Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hiroharu Yamashita

Showing results (1-10 of 171) with videos related to

Pageof 18
Sort By:
Kyobu Geka. the Japanese Journal of Thoracic Surgery|February 9, 2017
[Treatment Strategy for Esophagogastric Junction Carcinoma;Highly Controversial Topic in the Upper Gastrointestinal Malignancy]Hiroharu Yamashita, Yasuyuki Seto
Nihon Geka Gakkai Zasshi|April 7, 2015
[Optimal surgical approach for esophagogastric junction carcinoma]Hiroharu Yamashita, Yasuyuki Seto
Japanese Journal of Clinical Oncology|September 28, 2005
Hyperfibrinogenemia is a useful predictor for lymphatic metastasis in human gastric cancerHiroharu Yamashita, Joji Kitayama, Hirokazu Nagawa
World Journal of Gastroenterology|February 16, 2016
Glucose metabolism in gastric cancer: The cutting-edgeLian-Wen Yuan, Hiroharu Yamashita, Yasuyuki Seto
Annals of Translational Medicine|November 9, 2019
Gastric cancer surgery: historical background and perspective in Western countries versus JapanChun-Dong Zhang, Hiroharu Yamashita, Yasuyuki Seto
Journal of Surgical Oncology|October 27, 2006
Tissue factor expression is a clinical indicator of lymphatic metastasis and poor prognosis in gastric cancer with intestinal phenotypeHiroharu Yamashita, Joji Kitayama, Makoto Ishikawa, et al.
World Journal of Surgery|July 26, 2017
Comparison of Prognostic Abilities Among Preoperative Laboratory Data Indices in Patients with Resectable Gastric and Esophagogastric Junction AdenocarcinomaMasayuki Urabe, Hiroharu Yamashita, Toshiaki Watanabe, et al.
World Journal of Surgery|March 25, 2009
Intraoperative blood loss is a critical risk factor for peritoneal recurrence after curative resection of advanced gastric cancerTakao Kamei, Joji Kitayama, Hiroharu Yamashita, et al.
Annals of Surgical Oncology|October 23, 2016
Increasing the Number of Examined Lymph Nodes is a Prerequisite for Improvement in the Accurate Evaluation of Overall Survival of Node-Negative Gastric Cancer PatientsJingyu Deng, Hiroharu Yamashita, Yasuyuki Seto, et al.
Surgery|January 24, 2017
Re-evaluating the prognostic validity of the negative to positive lymph node ratio in node-positive gastric cancer patientsHiroharu Yamashita, Jingyu Deng, Han Liang, et al.
Pageof 18

Showing results (1-10 of 171) with videos related to

Sort By:
Pageof 18
Kyobu Geka. the Japanese Journal of Thoracic Surgery|February 9, 2017
[Treatment Strategy for Esophagogastric Junction Carcinoma;Highly Controversial Topic in the Upper Gastrointestinal Malignancy]Hiroharu Yamashita, Yasuyuki Seto
Nihon Geka Gakkai Zasshi|April 7, 2015
[Optimal surgical approach for esophagogastric junction carcinoma]Hiroharu Yamashita, Yasuyuki Seto
Japanese Journal of Clinical Oncology|September 28, 2005
Hyperfibrinogenemia is a useful predictor for lymphatic metastasis in human gastric cancerHiroharu Yamashita, Joji Kitayama, Hirokazu Nagawa
World Journal of Gastroenterology|February 16, 2016
Glucose metabolism in gastric cancer: The cutting-edgeLian-Wen Yuan, Hiroharu Yamashita, Yasuyuki Seto
Annals of Translational Medicine|November 9, 2019
Gastric cancer surgery: historical background and perspective in Western countries versus JapanChun-Dong Zhang, Hiroharu Yamashita, Yasuyuki Seto
Journal of Surgical Oncology|October 27, 2006
Tissue factor expression is a clinical indicator of lymphatic metastasis and poor prognosis in gastric cancer with intestinal phenotypeHiroharu Yamashita, Joji Kitayama, Makoto Ishikawa, et al.
World Journal of Surgery|July 26, 2017
Comparison of Prognostic Abilities Among Preoperative Laboratory Data Indices in Patients with Resectable Gastric and Esophagogastric Junction AdenocarcinomaMasayuki Urabe, Hiroharu Yamashita, Toshiaki Watanabe, et al.
World Journal of Surgery|March 25, 2009
Intraoperative blood loss is a critical risk factor for peritoneal recurrence after curative resection of advanced gastric cancerTakao Kamei, Joji Kitayama, Hiroharu Yamashita, et al.
Annals of Surgical Oncology|October 23, 2016
Increasing the Number of Examined Lymph Nodes is a Prerequisite for Improvement in the Accurate Evaluation of Overall Survival of Node-Negative Gastric Cancer PatientsJingyu Deng, Hiroharu Yamashita, Yasuyuki Seto, et al.
Surgery|January 24, 2017
Re-evaluating the prognostic validity of the negative to positive lymph node ratio in node-positive gastric cancer patientsHiroharu Yamashita, Jingyu Deng, Han Liang, et al.
Pageof 18